MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 10402-53-6
MCE 国际站:Eprazinone dihydrochloride
产品活性:Eprazinone dihydrochloride 是一种具有粘液溶解,分泌分解,镇咳和支气管解痉性质的活性分子。Eprazinone dihydrochloride 是一种神经激肽 1 受体 (NK1R) 的配体。Eprazinone dihydrochloride 可用于慢性支气管炎的研究,可改善肺功能和动脉血氧分压。
研究领域:GPCR/G Protein | Neuronal Signaling
作用靶点:Neurokinin Receptor
In Vitro: Eprazinone specifically displaces binding to the NK1R. Although Eprazinone displays a rather weak inhibition of [125I]BH-SP binding to NK1R, at a concentration of 25 μM, and an antagonistic effect of about 30%, NK1R blockade could contribute to its mucolytic activity.
In Vivo: Eprazinone (50-200 mg/kg; oral gavage; daily; for 4 days; adult male rats) at a dose of 200 mg/kg significantly increases total and individual (with the exception of phosphatidylinositol) phospholipid levels and decreases total neutral lipids. Lower doses of Eprazinone significantly decrease neutral lipid levels without affecting the phospholipids.
In airway epithelial studies, mucosal addition of Eprazinone produces a dose-dependent partially reversible decrease in short-circuit current (Isc). The decrease in Isc at lower Eprazinone concentrations is accounted for entirely by a decrease in net chloride secretion while at higher concentrations both sodium and chloride transport are affected.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Immunology/Inflammation Compound Library | Neuronal Signaling Compound Library | FDA-Approved Drug Library | Drug Repurposing Compound Library | NMPA-Approved Drug Library | Neurotransmitter Receptor Compound Library | FDA Approved & Pharmacopeial Drug Library | Off-patent Drug Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Talnetant hydrochloride | [Tyr8,Nle11] Substance P | Neurokinin A(4-10) TFA | Maropitant-13C,d3 | [Sar4] Substance P (4-11) | MEN11467 | Spantide I TFA | [MePhe8,Sar9] Substance P | (β-Ala8)-Neurokinin A (4-10) | [MePhe7]-Neurokinin B | MLGFFQQPKPR-NH2 | Vapreotide acetate | Rolapitant | Biotin-NeurokininA | [D-Pro2,D-Trp7,9] Substance P | MEN 10207 | Ibodutant | Netupitant metabolite Monohydroxy Netupitant | Fezolinetant | SB-222200 | Neurokinin A TFA | Neurokinin B TFA | Septide | CS-003 Free base | Phyllomedusin | Imnopitant | Men 10376 TFA | [Lys5,MeLeu9,Nle10]-NKA(4-10) | Fosaprepitant dimeglumine
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
货号: HY-B2078A
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。